The UK’s huge programme to lower blood-sugar levels really worked
Diabetes prevention in the low-income population: an experiment to investigate the relation between blood glucose levels and remission rates in the United States and in Europe
Many of those who do not participate in the programme are members of minority-ethnic communities that are at particularly high risk of diabetes and its complications, says Eleanor Barry, a physician who studies diabetes risk at the Nuffield Department of Primary Care Health Sciences at the University of Oxford, UK. “There is a risk of the intervention widening health inequalities between those who are able to engage — and subsequently reduce their diabetes risk — and those who are not,” she says.
Saeedi, P. et al. The International Diabetes Federation created a Diabetes Atlas to provide estimates of global and regional diabetes prevalence. There are a lot of people with Diabetes Res.cl. Pract. 157, 107843 (2019).
Participants in the English programme attend a minimum of 13 sessions, during which they are counselled on how to eat a healthy diet and maintain a healthy weight. Eligibility for the programme is determined by blood sugar level: once this biomarker climbs above a certain threshold, a person is considered prediabetic and at high risk of developing diabetes.
Epidemiologist Pascal Geldsetzer at Stanford University in California and his colleagues took advantage of that cut-off point to conduct an experiment. People with scores slightly below the threshold are rarely referred to the programme — even though there is no such sharp boundary in biological diabetes risk.
While there was no analysis regarding whether participants went on to develop type 2 diabetes, there was a correlation between drops in blood sugar and improvements in cardiovascular health.
Overall, the outcome is similar to those found in clinical trials and smaller evaluations of prevention programmes, says Earle Chambers, an epidemiologist at the Albert Einstein College of Medicine in New York City. The high attrition rate from the programme is a concern, he adds, saying less than one-third of people who are referred to the programme actually start it.
When a randomized trial isn’t available, big data is used to emulate a target trial. Am. J. Epidemiol. 182, 752–754.
Clinical codelist for the hospital episode statistics admitted patient care (HES APC): a case study in a group of patients with angiodystrophy
Davidson, J. Clinical codelist—HES—Major Adverse Cardiovascular Event. London School of Hygiene & Tropical Medicine https://doi.org/10.17037/DATA.00002198 (2021).
Titiunik, R, Calonico, S., and Cattaneo, M.D., studied vonfidence intervals for regression-discontinuity designs. Econometrica 83, 2 295–2326.
Lower Layer Super Output Area (2011) to Clinical Commissioning Group to Local Authority District (April 2021) It is possible to find it in England. The Office of National Statistics has a set of data on the lower-layer super output area.
Chatton, A. et al. A comparative simulations study using propensity score-based methods and targeted maximum likelihood estimators for causality inference. 10, 9219 will be published in 2020.
N. & E. A. are related. Choosing the causal estimand for propensity score analysis of observational studies. You can read the Preprint at www.doi.org/10.48550/ARXIV.
A case study in a group of patients with angiodystrophy. J. Comp. Eff. Res. 9, 395–403 was published in 2020.
Herbert, A., Wijlaars, L., Zylbersztejn, A., Cromwell, D. & Hardelid, P. Data resource profile: Hospital Episode Statistics Admitted Patient Care (HES APC). Int. J. Epidemiol is a drug. 46,109-093i was published in 2017:
The nationaldiabetesaudit.org is the place to go for a diabetes audit. Other reports and statistics are included in the audit. The National Diabetesaudit is found in the data and information section of the website.
Source: Quasi-experimental evaluation of a nationwide diabetes prevention programme
Systematic review and meta-analysis of studies on the use of social prescribing in individual-level type 2 diabetes prevention: A systematic review
Silverio, A. Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients. A journal about Cardiovasc. Disord. 21st, 22nd and 23rd of 2021.
Caldern-Larraaga, S. Unravelling the potential of social prescribing in individual-level type 2 diabetes prevention: a mixed-methods realist evaluation. BMC Med. 21, 91 (2023).
Galaviz, K. I. et al. Interventions for reversing prediabetes were evaluated in a systematic review. Am. The last paragraph of J. Prev. It was published in the journal j.amepre. 2021.10,020.
D. E., Jonas, and others. The US Preventive Services Task Force has recommended that prediabetes and type 2 Diabetes be screened. JAMA 326, 744 (2021).
R. Persson, and et al. CPRD Aurum database: assessment of data quality and completeness of three important comorbidities. A group of compounds that include Pharmacoepidemiol. Drug Saf. 29, 1456–1464, was published in 2020.
The negative controls are a tool that can detect bias in observational studies. Epidemiology 21, 383–388 (2010).
Garg, N. et al. Hemoglobin A1c in nondiabetic patients: an independent predictor of coronary artery disease and its severity. Mayo Clin. A Proc. 89 was presented in the winter of 2014).
Comparison of clinical characteristics between trial participants and non participants using electronic health record data. JAMA Netw. Open 4, e214732 (2021).
Kennedy-Martin, T., Curtis, S., Faries, D., Robinson, S. & Johnston, J. A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. Trials 16, 495 (2015).
Keyworth, C., Epton, T., Goldthorpe, J., Calam, R. & Armitage, C. J. ‘It’s difficult, I think it’s complicated’: Health care professionals’ barriers and enablers to providing opportunistic behaviour change interventions during routine medical consultations. Br. J. Health Psychol. It was published in the peer reviewed journal Becker’s Handbook of Human Performance (12368) on Thursday, January 24, 2019.
Irving, G. et al. International variations in primary care physician consultation time: a systematic review of 67 countries. The 7th edition of the open book, the BMJ Open.
Lemp, J. M. Use of lifestyle interventions in primary care for individuals with newly diagnosed hypertension, hyperlipidaemia or obesity: a retrospective cohort study. R. Soc. The Med 115, numbered at least in part, was written in the year 2022.
The Diabetes Prevention Program Research Group is researching diabetes. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. The journal published an article entitled “Diabetes Endocrinol. 3.”
Source: Quasi-experimental evaluation of a nationwide diabetes prevention programme
Weightedness in Primary Care: A Systematic Review and Prospects for a Cross-Sectional Intervention in Type 2 Diabetes
In routine clinical consultations, physicians talk about weight management. The patient is in the classroom. Couns. 100, 897–908 (2017).
Hébert, E. T., Caughy, M. O. & Shuval, K. Primary care providers’ perceptions of physical activity counselling in a clinical setting: a systematic review. Br. J. Sports Med. 46, 625–631 (2012).
Rubio-Valera, M. et al. Barriers and facilitators are used for the implementation of primary prevention and health promotion activities. There is a 9, e89554 issue of PLoS ONE.
Taheri, S. et al. An open-label parallel-group, randomised controlled trial examines the effect of intensive lifestyle intervention on weight and blood sugar in type 2 diabetes. The Lancet Diabetes Endrinol. 8, 476–499, will be published in 2020.
Bommer, C. et al. The study looked at how much it cost to be affected by diabetes in people between the ages of 20 and 29 years. 5, 423–430 were published in the journal Lancet Diabetes.
Many participants in a UK national diabetes prevention programme who do not participate in the programme are members of minority-ethnic communities that are at particularly high risk of diabetes and its complications, scientists have said. Eligibility for the programme is determined by blood sugar level. The researchers said there was a correlation between drops in blood sugar and improvements in cardiovascular health.